CLB-100

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCLB-100
Drug Alias NameCLB-100
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionFibrinogen antagonists
TargetsFibrinogen
Therapy Area/Indications +[1N/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEmory University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEmory University
Active IndicationsN/A
Inactive Indications +[1N/A

Other Information

ATC CodeN/A
Related LinksN/A